Clotting with CVVH vs CVVHD (Mottes et al, CRRT 1999)

Download Report

Transcript Clotting with CVVH vs CVVHD (Mottes et al, CRRT 1999)

Complications of Pediatric CRRT
Theresa A. Mottes RN
Pediatric Dialysis/Research Nurse
C.S. Mott Children’s Hospital
University of Michigan
Complications of Pediatric CRRT
 Temperature instability
 Hemodynamic instability
 Anticoagulation Risk
 Circuit/Access Complications
Factors effecting hemodynamics
 Patient Volume Status
• Ultrafiltration Rate
– patients hemodynamic
– typically vasopressor dependent
– patients intravascular volume
• Ultrafiltration Rate
– 1-2ml/kg/hour net ultrafiltration
– absolute necessity to control ultrafiltration
– error of accurate ultrafiltration monitoring
RESULTS
(Smoyer et al, CRRT 1997)
Trilogy Pump: Accuracy over Range of Flow Rates
4
Dialysate
3
Ultrafiltrate
% Error
2
1
0
-1
-2
-3
-4
0
100 200 300 400 500 600 700 800 900 1000
IV Pump Flow Rate (ml/hr)
Ccs/hr
Ultrafiltration accuracy
2.8 kg infant on PRISMA
100
90
80
70
60
50
40
30
20
10
0
Prescribed net U/F
Actual net U/F
1
2
3
4
Hour of Therapy
Prescription
BFR 30 mls/min
Dx FR 300 mls/hr
avg/4
hrs
Factors effecting hemodynamics
 What now?
• Hourly assessment of Intake and Output
• Hourly Ultrafiltration calculations
– adjusting for pump error
• Accurate measuring of Ultrafiltration
• Close monitoring of hemodynamics
• Accurate daily weight
Factors effecting hemodynamics
 Calculation for Pump Error
Factors effecting hemodynamics
 Vasopressor clearance
• Vasopressor agents all have in common a
small molecular weight and minimal protein
binding
– Epinephrine
– Norepinephrine
– Dopamine
– Dobutamine
Factors effecting hemodynamics
 Vasopressors
• Due to proximity of infusion
– be aware of infusing vasopressor agents in
immediate proximity to the “arterial” port of the
hemofiltration machine
– potential for recirculation
– effects delivery and clearance
Intravascular Blood Volume
 < 10 kg 80 ml/kg
• e.g. 8 kg infant = 640 ml intravascular volume
 > 10 kg 70 ml/kg
• e.g. 20 kg child has 1.4 liter intravascular
volumeBlood

Priming Hemofiltration Circuit
• Recommended when circuit volume > 10 % of
patients intravascular blood volume
Anticoagulation
 Heparin
 Citrate
 None
Circuit Complications
Circuit Clotting
•
•
•
•
Inability to ultrafiltrate desired amount
Increasing Access/Return Pressure
Inadequate clearances
Observe clotting in filter/ tubing
Clotting with CVVH vs CVVHD
(Mottes et al, CRRT 1999)
RRT
PreHF
HCT
Post HF Delta Hct
HCT
change
27%
44%
62%
Post-filter
Replacement
36%
46%
27%
CVVHD
32%
34%
6%
CVVH
Pre-filter
Replacement
CVVH
Flow Rates
 Blood
• 5-10 ml/kg/min keeping venous pressure
under 200 mm Hg
 Dialysate/Replacement fluid
• 2 liters/1.73 m2/hr
– (extrapolation of adult data)
Access Complications
 What is the correct access?
• One that works
In Flow Difficulties
 Obstruction or clot on the return line
• high intrathoracic pressure with HIFI
• up against the vessel wall
 Clamp on inflow
 Access kinked at skin site
 Consider reversing or changing access
Out Flow Difficulties
 Clamp on access/”arterial” line
 Inflow port up against vessel wall
 Patient “dry” eg with femoral site
 High of blood flow requirements based
upon flow ability of access
 Consider
• reverse flow, change access, decrease blood
flow rates